Indications and drugs for anticoagulation therapy in children.
The indications for using anticoagulants in children are reviewed. These include venous thromboembolic disease, thrombosis associated with central venous lines, inherited conditions, arterial thromboembolic disease and umbilical catheterization. The anticoagulants presently available for paediatric use consist of heparin and oral agents including low molecular weight heparin (LMWH). The problems associated with their use in children are examined and potential advantages described. Increasing numbers of children are now requiring anticoagulant therapy and the potential advantages of LMWHs makes it imperative that randomized, controlled trials be carried out in children in prophylactic as well as therapeutic situations.
Andrew
M
M
Hamilton Civic Hospitals Research Centre, Ontario, Canada.
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D002648:Child; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D011183:Postoperative Complications / Q000188:drug therapy; D013552:Swine; D013923:Thromboembolism / Q000188:drug therapy* / Q000209:etiology
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight